Pharma-Bio Serv, Inc.

0.5760

-0.0140-2.37%

Volume:600.00

Turnover:346.93

Market Cap:13.20M

PE:-131.60

High:0.5800

Open:0.5800

Low:0.5760

Close:0.5900

52wk High:1.36

52wk Low:0.3451

Shares:22.92M

Float Shares:7.32M

Volume Ratio:0.13

T/O Rate:0.01%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.0044

EPS(LYR):0.0554

ROE:-0.78%

ROA:-2.66%

PB:1.11

PE(LYR):10.39

Loading ...

Overview Company News Filings

Concept

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Pharma-Bio Serv reports FY gross profit of USD 2.9 million, up 22 percent

Reuters

·

Jan 30

Pharma-Bio Serv Inc. Reports 6.6% Increase in Gross Profit Margin for Three Months Ending July 31, 2025, Despite Projected Revenue Decline in Key Markets

Reuters

·

Sep 16, 2025

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/PBSV"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PBSV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBSV\",,,,,undefined,":{"symbol":"PBSV","market":"US","secType":"STK","nameCN":"Pharma-Bio Serv, Inc.","latestPrice":0.576,"timestamp":1771621200000,"preClose":0.59,"halted":0,"volume":600,"delay":15,"changeRate":-0.023728813559322055,"floatShares":7320556,"shares":22918092,"eps":-0.004377,"marketStatus":"Market Closed","change":-0.014,"latestTime":"02-20 16:00:00 EST Delay","open":0.58,"high":0.58,"low":0.576,"amount":346.92999999999995,"amplitude":0.00678,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.004377,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1771837200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"OTCQB","adjPreClose":0.59,"volumeRatio":0.130412103093454},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBSV\",,,,,undefined,":{"symbol":"PBSV","floatShares":7320556,"roa":"-2.66%","roe":"-0.78%","lyrEps":0.055445,"volumeRatio":0.130412103093454,"shares":22918092,"dividePrice":0,"high":0.58,"amplitude":0.00678,"preClose":0.59,"low":0.576,"week52Low":0.3451,"pbRate":"1.11","psRate":"1.47","week52High":1.36,"institutionHeld":0,"latestPrice":0.576,"eps":-0.004377,"divideRate":0,"volume":600,"delay":15,"ttmEps":-0.004377,"open":0.58,"prevYearClose":0.6,"prevWeekClose":0.5932,"prevMonthClose":0.5946,"prevQuarterClose":0.6,"fiveDayClose":0.5932,"twentyDayClose":0.54,"sixtyDayClose":0.5485},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PBSV\",params:#limit:5,,,undefined,":[{"date":"2026-02-27","symbol":"PBSV","amount":0.075,"announcedDate":"2026-01-29","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-02-27","defaultRemindTime":1772202600000,"name":"Pharma-Bio Serv, Inc.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-20","payableDate":"2026-02-27","currency":"USD","dateTimestamp":1772168400000,"payDate":"2026-03-20"},{"date":"2025-02-28","symbol":"PBSV","amount":0.075,"announcedDate":"2025-01-29","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-02-28","defaultRemindTime":1740753000000,"name":"Pharma-Bio Serv, Inc.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-20","payableDate":"2025-02-28","currency":"USD","dateTimestamp":1740718800000,"payDate":"2025-03-20"},{"market":"US","date":"2024-09-16","symbol":"PBSV","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1726459200000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-06-14","symbol":"PBSV","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1718337600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-03-18","symbol":"PBSV","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1710734400000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PBSV\",market:\"US\",,,undefined,":[{"executeDate":"2018-10-12","recordDate":"2018-10-15","paymentDate":"2018-10-26","value":0.075,"currency":"USD"},{"executeDate":"2019-11-01","recordDate":"2019-11-04","paymentDate":"2019-11-15","value":0.075,"currency":"USD"},{"executeDate":"2021-01-22","recordDate":"2021-01-25","paymentDate":"2021-02-05","value":0.075,"currency":"USD"},{"executeDate":"2021-12-14","recordDate":"2021-12-15","paymentDate":"2022-01-03","value":0.075,"currency":"USD"},{"executeDate":"2022-02-24","recordDate":"2022-02-25","paymentDate":"2022-03-15","value":0.075,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PBSV\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PBSV\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2607054851","title":"Pharma-Bio Serv reports FY gross profit of USD 2.9 million, up 22 percent","url":"https://stock-news.laohu8.com/highlight/detail?id=2607054851","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607054851?lang=en_us&edition=fundamental","pubTime":"2026-01-30 05:50","pubTimestamp":1769723434,"startTime":"0","endTime":"0","summary":"Pharma-Bio Serv Inc. reported its financial results for the full year ended October 31, 2025. Total revenue for the period was USD 9.0 million. The company recorded a net loss of USD 0.1 million. Cost of services amounted to USD 6.1 million. The European market contributed an increase in project revenue, while revenues in Puerto Rico, the United States, and Brazil experienced declines. Gross profit margin improved by 5.8 percentage points, mainly due to margin enhancements in the Puerto Rico and United States consulting markets and a high-margin project in Europe.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pharma-Bio Serv Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260129:nNDLzQ0RM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","PBSV"],"gpt_icon":0},{"id":"2567037147","title":"Pharma-Bio Serv Inc. Reports 6.6% Increase in Gross Profit Margin for Three Months Ending July 31, 2025, Despite Projected Revenue Decline in Key Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2567037147","media":"Reuters","labels":["dataReport","event","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567037147?lang=en_us&edition=fundamental","pubTime":"2025-09-16 04:53","pubTimestamp":1757969632,"startTime":"0","endTime":"0","summary":"Pharma-Bio Serv Inc. Reports 6.6% Increase in Gross Profit Margin for Three Months Ending July 31, 2025, Despite Projected Revenue Decline in Key Markets. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pharma-Bio Serv Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on September 15, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250915:nNDL6dyQYC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,event,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBSV"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":2,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/PBSV\",params:#limit:6,delay:false,,,undefined,":[]}}